{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:29:50Z","timestamp":1771032590845,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":1118,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"University of Pennsylvania Orphan Disease Center","award":["MDR-16-115-TSA"],"award-info":[{"award-number":["MDR-16-115-TSA"]}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1177\/2472555218814538","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T14:31:26Z","timestamp":1546957886000},"page":"295-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Patient-Derived Phenotypic High-Throughput Assay to Identify Small Molecules Restoring Lysosomal Function in Tay\u2013Sachs Disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Dennis J.","family":"Colussi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1177\/2472555218814538_bib1","first-page":"1","article-title":"Storage Solutions: Treating Lysosomal Disorders of the Brain","volume":"6","author":"Jeyakumar","year":"2005","journal-title":"Nat. Rev. Neurol."},{"key":"10.1177\/2472555218814538_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"The Cell Biology of Disease: Lysosomal Storage Disorders: The Cellular Impact of Lysosomal Dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1177\/2472555218814538_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1098-1004(1997)9:3<195::AID-HUMU1>3.0.CO;2-7","article-title":"Tay-Sachs Disease-Causing Mutations and Neutral Polymorphisms in the Hex A Gene","volume":"9","author":"Myerowitz","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1177\/2472555218814538_bib4","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","article-title":"Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic Pathogenesis","volume":"33","author":"Sandhoff","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1177\/2472555218814538_bib5","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1542\/peds.2011-0078","article-title":"Natural History of Infantile G(M2) Gangliosidosis","volume":"128","author":"Bley","year":"2011","journal-title":"Pediatrics"},{"key":"10.1177\/2472555218814538_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1469-8749.2011.04160.x","article-title":"GM2 Gangliosidosis in a UK Study of Children with Progressive Neurodegeneration: 73 Cases Reviewed","volume":"54","author":"Smith","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1177\/2472555218814538_bib7","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1074\/jbc.M609304200","article-title":"Pyrimethamine as a Potential Pharmacological Chaperone for Late-Onset Forms of GM2 Gangliosidosis","volume":"282","author":"Maegawa","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1177\/2472555218814538_bib8","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1111\/j.1742-4658.2007.06040.x","article-title":"Lending a Helping Hand, Screening Chemical Libraries for Compounds That Enhance \u03b2-Hexosaminidase A Activity in GM2 Gangliosidosis Cells","volume":"274","author":"Tropak","year":"2007","journal-title":"FEBS J."},{"key":"10.1177\/2472555218814538_bib9","doi-asserted-by":"crossref","first-page":"13192","DOI":"10.1073\/pnas.0705637104","article-title":"Three Classes of Glucocerebrosidase Inhibitors Identified by Quantitative High-Throughput Screening Are Chaperone Leads for Gaucher Disease","volume":"104","author":"Zheng","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1177\/2472555218814538_bib10","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1177\/2472555218814538_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2010.09.004","article-title":"An Open-Label Phase I\/II Clinical Trial of Pyrimethamine for the Treatment of Patients Affected with Chronic GM2 Gangliosidosis (Tay-Sachs or Sandhoff Variants)","volume":"102","author":"Clarke","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1177\/2472555218814538_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol Chaperone Therapy for Neuronopathic Gaucher Disease: A Pilot Study","volume":"3","author":"Narita","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1177\/2472555218814538_bib13","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1177\/1087057113501199","article-title":"The Contribution of Mechanistic Understanding to Phenotypic Screening for First-in-Class Medicines Phenotypic Assays in Drug Discovery","volume":"18","author":"Swinney","year":"2013","journal-title":"J. Biomol. Screen."},{"key":"10.1177\/2472555218814538_bib14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2013.07.001","article-title":"Phenotypic Screens as a Renewed Approach for Drug Discovery","volume":"18","author":"Zheng","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1177\/2472555218814538_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/BJ20110949","article-title":"Molecular Mechanisms of Endolysosomal Ca2+ Signaling in Health and Disease","volume":"439","author":"Morgan","year":"2011","journal-title":"Biochem. J."},{"key":"10.1177\/2472555218814538_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ceca.2011.03.010","article-title":"Lysosomal Ca(2+) Homeostasis: Role in Pathogenesis of Lysosomal Storage Diseases","volume":"50","author":"Lloyd-Evans","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1177\/2472555218814538_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ceca.2009.12.007","article-title":"Aberrant Ca2+ Handling in Lysosomal Storage Disorders","volume":"47","author":"Kiselyov","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1177\/2472555218814538_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1166\/msr.2016.1053","article-title":"Deviant Lysosomal Ca2+ Signaling in Neurodegeneration. An Introduction","volume":"5","author":"Patel","year":"2016","journal-title":"Messenger"},{"key":"10.1177\/2472555218814538_bib19","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nm.1876","article-title":"Niemann-Pick Disease Type C1 is a Sphingosine Storage Disease that Causes Deregulation of Lysosomal Calcium","volume":"14","author":"Lloyd-Evans","year":"2008","journal-title":"Nat. Med."},{"key":"10.1177\/2472555218814538_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1242\/jcs.118836","article-title":"Direct Mobilisation of Lysosomal Ca2+ Triggers Complex Ca2+ Signals","volume":"126","author":"Kilpatrick","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1177\/2472555218814538_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"key":"10.1177\/2472555218814538_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/bj3000229","article-title":"Use of Glycyl-L-Phenylalanin 2-Napthylamide, a Lysosome-Disrupting Capthepsin C Substrate to Distinguish between Lysosomes and Prelysosomal Endocytic Vacuoles","volume":"300","author":"Berg","year":"1994","journal-title":"Biochem. J."},{"key":"10.1177\/2472555218814538_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/bs.mcb.2014.10.027","article-title":"Measuring Relative Lysosomal Volume for Monitoring Lysosomal Storage Diseases","volume":"126","author":"te Vruchte","year":"2015","journal-title":"Methods Cell Biol."},{"key":"10.1177\/2472555218814538_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1087057113501197","article-title":"A Phenotypic Compound Screening Assay for Lysosomal Storage Diseases","volume":"19","author":"Xu","year":"2014","journal-title":"J. Biomol. Screen."},{"key":"10.1177\/2472555218814538_bib25","doi-asserted-by":"crossref","first-page":"13478","DOI":"10.1074\/jbc.M308523200","article-title":"Pharmacological Enhancement of \u03b2-Hexosaminidase Activity in Fibroblasts from Adult Tay-Sachs and Sandhoff Patients","volume":"279","author":"Tropak","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1177\/2472555218814538_bib26","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1002\/ijc.26420","article-title":"Differential Effects of the Glycolysis Inhibitor 2-deoxy-D-Glucose on the Activity of the Pro-Apoptotic Agents in Metastatic Melanoma Cells and Induction of a Cytoprotective Autophagic Response","volume":"131","author":"Giammarioli","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1177\/2472555218814538_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4161\/auto.19469","article-title":"Autophagy in Lysosomal Storage Disorders","volume":"8","author":"Lieberman","year":"2012","journal-title":"Autophagy"},{"key":"10.1177\/2472555218814538_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/EBC20170055","article-title":"Dysregulation of Autophagy as a Common Mechanism in Lysosomal Storage Diseases","volume":"61","author":"Seronova","year":"2017","journal-title":"Essays Biochem."}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555218814538","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2472555218814538","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222126080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222126080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555218814538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:51:56Z","timestamp":1762861916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555222126080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2472555222126080"],"URL":"https:\/\/doi.org\/10.1177\/2472555218814538","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Derived Phenotypic High-Throughput Assay to Identify Small Molecules Restoring Lysosomal Function in Tay\u2013Sachs Disease","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/2472555218814538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}